{
    "ABILIFY MAINTENA 400MG SUSP ER": [
        {
            "ICD_10_Code": "F20.9",
            "ICD_Description": "F20.9 stands for Schizophrenia, unspecified."
        },
        {
            "ICD_10_Code": "F31.13",
            "ICD_Description": "F31.13 stands for Bipolar I disorder, current episode mixed, moderate."
        },
        {
            "ICD_10_Code": "F31.14",
            "ICD_Description": "F31.14 stands for Bipolar I disorder, current episode mixed, severe, with psychotic features."
        },
        {
            "ICD_10_Code": "F31.9",
            "ICD_Description": "F31.9 stands for Bipolar affective disorder, unspecified."
        }
    ],
    "ACCRUFER 30 MG ORAL CAPSULE": [
        {
            "ICD_10_Code": "D50.0",
            "ICD_Description": "D50.0 stands for Iron deficiency anemia secondary to blood loss (chronic)."
        },
        {
            "ICD_10_Code": "D50.8",
            "ICD_Description": "D50.8 stands for Iron deficiency anemia due to blood loss (chronic)."
        },
        {
            "ICD_10_Code": "D50.9",
            "ICD_Description": "D50.9 stands for Iron deficiency anemia, unspecified."
        }
    ],
    "ACYCLOVIR 5% OINTMENT": [
        {
            "ICD_10_Code": "B00.0",
            "ICD_Description": "B00.0 stands for Herpes simplex [herpesvirus] infections of the lips, mouth, gums, and pharynx."
        },
        {
            "ICD_10_Code": "B00.1",
            "ICD_Description": "B00.1 stands for Herpes simplex virus infections of the lips."
        },
        {
            "ICD_10_Code": "B00.9",
            "ICD_Description": "B00.9 stands for Herpesviral infection, unspecified site."
        },
        {
            "ICD_10_Code": "B02.9",
            "ICD_Description": "B02.9 stands for Zoster without complications."
        }
    ],
    "ADMELOG SOLOSTAR 100UNIT/ML INJECTION": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E13.9",
            "ICD_Description": "E13.9 stands for Other specified diabetes mellitus with other specified complication."
        }
    ],
    "ADZENYS XR-ODT 15.7 MG ORAL TABLET EXTENDED RELEASE DISINTEGRATING": [
        {
            "ICD_10_Code": "F90.0",
            "ICD_Description": "F90.0 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.1",
            "ICD_Description": "F90.1 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.9",
            "ICD_Description": "F90.9 stands for Attention-deficit hyperactivity disorder, unspecified."
        }
    ],
    "AFREZZA 4 & 8 & 12UNIT POWDER": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "AIMOVIG 140 MG/ML SUBCUTANEOUS SOLUTION AUTO-INJECTOR": [
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        }
    ],
    "AIRSUPRA 90-80MCG/ACTUATION AER": [
        {
            "ICD_10_Code": "J45.40",
            "ICD_Description": "J45.40 stands for Moderate persistent asthma, uncomplicated."
        },
        {
            "ICD_10_Code": "J45.50",
            "ICD_Description": "J45.50 stands for Mixed asthma, unspecified."
        },
        {
            "ICD_10_Code": "J45.909",
            "ICD_Description": "J45.909 stands for Asthma, unspecified, without status asthmaticus."
        }
    ],
    "AJOVY 225 MG/1.5ML SUBCUTANEOUS SOLUTION AUTO-INJECTOR": [
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.919",
            "ICD_Description": "G43.919 stands for Migraine, unspecified, intractable."
        },
        {
            "ICD_10_Code": "G43.929",
            "ICD_Description": "G43.929 stands for Migraine, unspecified, intractable."
        },
        {
            "ICD_10_Code": "G43.939",
            "ICD_Description": "G43.939 stands for Migraine, unspecified, intractable."
        }
    ],
    "AKLIEF 0.005% CRM": [
        {
            "ICD_10_Code": "L70.0",
            "ICD_Description": "L70.0 stands for Acne vulgaris."
        },
        {
            "ICD_10_Code": "L70.9",
            "ICD_Description": "L70.9 stands for Acne, unspecified."
        }
    ],
    "AMPHETAMINE-DEXTROAMPHETAMINE 10 MG ORAL TABLET": [
        {
            "ICD_10_Code": "F90.0",
            "ICD_Description": "F90.0 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.1",
            "ICD_Description": "F90.1 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.2",
            "ICD_Description": "F90.2 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        }
    ],
    "ANNOVERA 0.013-0.15MG/24HR RING": [
        {
            "ICD_10_Code": "Z30.015",
            "ICD_Description": "Z30.015 stands for Encounter for insertion of etonogestrel-releasing vaginal ring."
        },
        {
            "ICD_10_Code": "Z30.44",
            "ICD_Description": "Z30.44 stands for Encounter for insertion of vaginal ring."
        }
    ],
    "ARAZLO 0.045% LOT": [
        {
            "ICD_10_Code": "L70.0",
            "ICD_Description": "L70.0 stands for Acne vulgaris."
        },
        {
            "ICD_10_Code": "L70.9",
            "ICD_Description": "L70.9 stands for Acne, unspecified."
        }
    ],
    "AUSTEDO XR (deutetrabenazine) 30MG ER tablets": [
        {
            "ICD_10_Code": "G10",
            "ICD_Description": "G10 stands for Huntington's disease."
        },
        {
            "ICD_10_Code": "G24.01",
            "ICD_Description": "G24.01 stands for Generalized idiopathic torsion dystonia."
        }
    ],
    "AUVELITY 45-105 MG ORAL TABLET EXTENDED RELEASE": [
        {
            "ICD_10_Code": "F32.9",
            "ICD_Description": "F32.9 stands for Major depressive disorder, single episode, unspecified."
        }
    ],
    "AZELAIC ACID 15 % EXTERNAL GEL": [
        {
            "ICD_10_Code": "L71.0",
            "ICD_Description": "L71.0 stands for Folliculitis decalvans."
        },
        {
            "ICD_10_Code": "L71.9",
            "ICD_Description": "L71.9 stands for Folliculitis, unspecified."
        }
    ],
    "AZELAIC ACID 15% GEL": [
        {
            "ICD_10_Code": "L70.0",
            "ICD_Description": "L70.0 stands for Acne vulgaris."
        },
        {
            "ICD_10_Code": "L71.0",
            "ICD_Description": "L71.0 stands for Folliculitis decalvans."
        }
    ],
    "BASAGLAR 100U/ML INJ": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E13.9",
            "ICD_Description": "E13.9 stands for Other specified diabetes mellitus with other specified complication."
        }
    ],
    "BASAGLAR KWIKPEN 100 UNIT/ML SUBCUTANEOUS SOLUTION PEN-INJECTOR": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E13.9",
            "ICD_Description": "E13.9 stands for Other specified diabetes mellitus with other specified complication."
        }
    ],
    "BIJUVA 0.5-100 MG ORAL CAPSULE": [
        {
            "ICD_10_Code": "N95.1",
            "ICD_Description": "N95.1 stands for Postmenopausal atrophic vaginitis."
        }
    ],
    "BONJESTA 20-20 MG ORAL TABLET EXTENDED RELEASE": [
        {
            "ICD_10_Code": "O21.0",
            "ICD_Description": "O21.0 stands for Excessive vomiting in pregnancy, mild hyperemesis."
        }
    ],
    "BOTOX 200 UNIT INJECTION SOLUTION RECONSTITUTED": [
        {
            "ICD_10_Code": "G43.709",
            "ICD_Description": "G43.709 stands for Migraine, unspecified, not intractable, without status migrainosus."
        }
    ],
    "BREZTRI 160-9-4.8MCG/AC INH": [
        {
            "ICD_10_Code": "J44.9",
            "ICD_Description": "J44.9 stands for Chronic obstructive pulmonary disease, unspecified."
        }
    ],
    "BUDESONIDE-FORMOTEROL FUMARATE 160-4.5MCG/ACT AEROSOL": [
        {
            "ICD_10_Code": "J44.9",
            "ICD_Description": "J44.9 stands for Chronic obstructive pulmonary disease, unspecified."
        },
        {
            "ICD_10_Code": "J45.909",
            "ICD_Description": "J45.909 stands for Asthma, unspecified, without status asthmaticus."
        }
    ],
    "BYDUREON BCISE 2 MG/0.85ML": [
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "CAPLYTA 42 MG ORAL CAPSULE": [
        {
            "ICD_10_Code": "F20.9",
            "ICD_Description": "F20.9 stands for Schizophrenia, unspecified."
        },
        {
            "ICD_10_Code": "F31.9",
            "ICD_Description": "F31.9 stands for Bipolar affective disorder, unspecified."
        }
    ],
    "CEQUA 0.09 % OPHTHALMIC SOLUTION": [
        {
            "ICD_10_Code": "H04.121",
            "ICD_Description": "H04.121 stands for Blepharoconjunctivitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.122",
            "ICD_Description": "H04.122 stands for Blepharitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        }
    ],
    "CLINDAMYCIN PHOS-BENZOYL PEROX 1.2-3.75 % EXTERNAL GEL": [
        {
            "ICD_10_Code": "L70.0",
            "ICD_Description": "L70.0 stands for Acne vulgaris."
        },
        {
            "ICD_10_Code": "L70.9",
            "ICD_Description": "L70.9 stands for Acne, unspecified."
        }
    ],
    "COBENFY 100-20 MG ORAL CAPSULE": [
        {
            "ICD_10_Code": "M05.79",
            "ICD_Description": "M05.79 stands for Rheumatoid arthritis with other involvement of other organs or systems."
        },
        {
            "ICD_10_Code": "M25.50",
            "ICD_Description": "M25.50 stands for Pain in joint, unspecified."
        },
        {
            "ICD_10_Code": "R52",
            "ICD_Description": "R52 stands for Pain, unspecified."
        }
    ],
    "CONTRAVE 8-90MG TABLET": [
        {
            "ICD_10_Code": "E66.01",
            "ICD_Description": "E66.01 stands for Morbid (severe) obesity due to excess calories."
        },
        {
            "ICD_10_Code": "E66.3",
            "ICD_Description": "E66.3 stands for Overweight."
        },
        {
            "ICD_10_Code": "E66.9",
            "ICD_Description": "E66.9 stands for Obesity, unspecified."
        }
    ],
    "CYCLOBENZAPRINE HCL 5 MG ORAL TABLET": [
        {
            "ICD_10_Code": "M62.830",
            "ICD_Description": "M62.830 stands for Other myalgia."
        },
        {
            "ICD_10_Code": "M62.831",
            "ICD_Description": "M62.831 stands for Other muscle spasm."
        },
        {
            "ICD_10_Code": "M62.832",
            "ICD_Description": "M62.832 stands for Other specified disorders of muscle."
        },
        {
            "ICD_10_Code": "M62.833",
            "ICD_Description": "M62.833 stands for Other myositis, right upper arm."
        },
        {
            "ICD_10_Code": "M62.834",
            "ICD_Description": "M62.834 stands for Other myositis."
        },
        {
            "ICD_10_Code": "M62.835",
            "ICD_Description": "M62.835 stands for Other muscle spasm."
        },
        {
            "ICD_10_Code": "M62.836",
            "ICD_Description": "M62.836 stands for Muscle spasm of back, right side."
        },
        {
            "ICD_10_Code": "M62.837",
            "ICD_Description": "M62.837 stands for Other muscle spasm of right thigh."
        },
        {
            "ICD_10_Code": "M62.838",
            "ICD_Description": "M62.838 stands for Other myalgia."
        },
        {
            "ICD_10_Code": "M62.839",
            "ICD_Description": "M62.839 stands for Other myositis."
        },
        {
            "ICD_10_Code": "M62.9",
            "ICD_Description": "M62.9 stands for Unspecified myalgia."
        }
    ],
    "DAPAGLIFLOZIN PROPANEDIOL 10 MG ORAL TABLET": [
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "I50.9",
            "ICD_Description": "I50.9 stands for Heart failure, unspecified."
        },
        {
            "ICD_10_Code": "N18.9",
            "ICD_Description": "N18.9 stands for Chronic kidney disease, unspecified."
        }
    ],
    "DEXCOM G7 SENSOR": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "DEXLANSOPRAZOLE 60MG CAP": [
        {
            "ICD_10_Code": "K21.0",
            "ICD_Description": "K21.0 stands for Gastro-esophageal reflux disease with esophagitis."
        },
        {
            "ICD_10_Code": "K21.9",
            "ICD_Description": "K21.9 stands for Gastro-esophageal reflux disease without esophagitis."
        },
        {
            "ICD_10_Code": "K25.9",
            "ICD_Description": "K25.9 stands for Gastric ulcer, unspecified."
        },
        {
            "ICD_10_Code": "K26.9",
            "ICD_Description": "K26.9 stands for Gastro-esophageal reflux disease without esophagitis."
        }
    ],
    "DICLOFENAC SODIUM 2 % EXTERNAL SOLUTION": [
        {
            "ICD_10_Code": "M17.11",
            "ICD_Description": "M17.11 stands for Unilateral primary osteoarthritis, right knee."
        },
        {
            "ICD_10_Code": "M17.12",
            "ICD_Description": "M17.12 stands for Unilateral primary osteoarthritis, right knee."
        },
        {
            "ICD_10_Code": "M17.9",
            "ICD_Description": "M17.9 stands for Gonarthrosis, unspecified."
        }
    ],
    "DOXYLAMINE-PYRIDOXINE 10-10 MG ORAL TABLET DELAYED RELEASE": [
        {
            "ICD_10_Code": "O21.0",
            "ICD_Description": "O21.0 stands for Excessive vomiting in pregnancy, mild hyperemesis."
        }
    ],
    "DUPIXENT 300MG/2ML INJ": [
        {
            "ICD_10_Code": "J33.9",
            "ICD_Description": "J33.9 stands for Nasal polyp, unspecified."
        },
        {
            "ICD_10_Code": "J45.40",
            "ICD_Description": "J45.40 stands for Moderate persistent asthma, uncomplicated."
        },
        {
            "ICD_10_Code": "L20.9",
            "ICD_Description": "L20.9 stands for Atopic dermatitis, unspecified."
        }
    ],
    "Diclofenac Epolamine 1.3% Film": [
        {
            "ICD_10_Code": "M25.561",
            "ICD_Description": "M25.561 stands for Pain in right knee."
        },
        {
            "ICD_10_Code": "M25.562",
            "ICD_Description": "M25.562 stands for Pain in right knee."
        },
        {
            "ICD_10_Code": "M54.5",
            "ICD_Description": "M54.5 stands for Low back pain."
        },
        {
            "ICD_10_Code": "M79.1",
            "ICD_Description": "M79.1 stands for Myalgia."
        },
        {
            "ICD_10_Code": "M79.2",
            "ICD_Description": "M79.2 stands for Neuralgia and neuritis, unspecified."
        },
        {
            "ICD_10_Code": "M79.7",
            "ICD_Description": "M79.7 stands for Fibromyalgia."
        },
        {
            "ICD_10_Code": "S39.012A",
            "ICD_Description": "S39.012A stands for Strain of muscle, fascia and tendon at lower back level, right side, initial encounter."
        },
        {
            "ICD_10_Code": "S39.012D",
            "ICD_Description": "S39.012D stands for Open wound of lower back, subsequent encounter."
        },
        {
            "ICD_10_Code": "S39.012S",
            "ICD_Description": "S39.012S stands for Strain of muscle, fascia and tendon at lower back level, subsequent encounter."
        },
        {
            "ICD_10_Code": "S80.001A",
            "ICD_Description": "S80.001A stands for Superficial abrasion of right knee, initial encounter."
        },
        {
            "ICD_10_Code": "S80.001D",
            "ICD_Description": "S80.001D stands for Superficial injury of right knee, subsequent encounter."
        },
        {
            "ICD_10_Code": "S80.001S",
            "ICD_Description": "S80.001S stands for Superficial injury of right knee, unspecified."
        },
        {
            "ICD_10_Code": "S80.002A",
            "ICD_Description": "S80.002A stands for Superficial injury of unspecified part of right knee, initial encounter."
        },
        {
            "ICD_10_Code": "S80.002D",
            "ICD_Description": "S80.002D stands for Superficial laceration of left thigh, subsequent encounter."
        },
        {
            "ICD_10_Code": "S80.002S",
            "ICD_Description": "S80.002S stands for Superficial laceration of left lower leg, subsequent encounter."
        },
        {
            "ICD_10_Code": "S86.011A",
            "ICD_Description": "S86.011A stands for Contusion of right knee, initial encounter."
        },
        {
            "ICD_10_Code": "S86.011D",
            "ICD_Description": "S86.011D stands for Contusion of right thigh, subsequent encounter."
        },
        {
            "ICD_10_Code": "S86.011S",
            "ICD_Description": "S86.011S stands for Injury of muscle(s) and tendon(s) at lower leg level, right leg, subsequent encounter."
        },
        {
            "ICD_10_Code": "S93.401A",
            "ICD_Description": "S93.401A stands for Sprain of ankle, unspecified site, initial encounter."
        },
        {
            "ICD_10_Code": "S93.401D",
            "ICD_Description": "S93.401D stands for Sprain of ankle, unspecified, right ankle, subsequent encounter."
        },
        {
            "ICD_10_Code": "S93.401S",
            "ICD_Description": "S93.401S stands for Sprain of calcaneofibular ligament of right ankle, initial encounter."
        },
        {
            "ICD_10_Code": "S93.402A",
            "ICD_Description": "S93.402A stands for Sprain of ankle, unspecified site, initial encounter."
        },
        {
            "ICD_10_Code": "S93.402D",
            "ICD_Description": "S93.402D stands for Sprain of calcaneofibular ligament of right ankle, subsequent encounter."
        },
        {
            "ICD_10_Code": "S93.402S",
            "ICD_Description": "S93.402S stands for Sprain of inferior tibiofibular ligament, left leg, subsequent encounter."
        }
    ],
    "Diclofenac Potassium 25 MG Oral Tablet": [
        {
            "ICD_10_Code": "M15.9",
            "ICD_Description": "M15.9 stands for Osteoarthritis, unspecified site."
        },
        {
            "ICD_10_Code": "M25.50",
            "ICD_Description": "M25.50 stands for Pain in joint, unspecified."
        },
        {
            "ICD_10_Code": "M54.2",
            "ICD_Description": "M54.2 stands for Cervicalgia."
        },
        {
            "ICD_10_Code": "M54.5",
            "ICD_Description": "M54.5 stands for Low back pain."
        },
        {
            "ICD_10_Code": "M79.1",
            "ICD_Description": "M79.1 stands for Myalgia."
        },
        {
            "ICD_10_Code": "M79.2",
            "ICD_Description": "M79.2 stands for Neuralgia and neuritis, unspecified."
        },
        {
            "ICD_10_Code": "R52",
            "ICD_Description": "R52 stands for Pain, unspecified."
        }
    ],
    "ELYXYB 120 MG/4.8ML ORAL SOLUTION": [
        {
            "ICD_10_Code": "G43.009",
            "ICD_Description": "G43.009 stands for Migraine without aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.019",
            "ICD_Description": "G43.019 stands for Migraine with aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.109",
            "ICD_Description": "G43.109 stands for Migraine without aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.119",
            "ICD_Description": "G43.119 stands for Migraine with aura, intractable, not specified as with status migrainosus."
        },
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.919",
            "ICD_Description": "G43.919 stands for Migraine, unspecified, intractable."
        }
    ],
    "EMGALITY 120 MG/ML SUBCUTANEOUS SOLUTION AUTO-INJECTOR": [
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.919",
            "ICD_Description": "G43.919 stands for Migraine, unspecified, intractable."
        },
        {
            "ICD_10_Code": "G43.929",
            "ICD_Description": "G43.929 stands for Migraine, unspecified, intractable."
        },
        {
            "ICD_10_Code": "G43.939",
            "ICD_Description": "G43.939 stands for Migraine, unspecified, intractable."
        }
    ],
    "ESTRING 2MG RING": [
        {
            "ICD_10_Code": "N95.1",
            "ICD_Description": "N95.1 stands for Postmenopausal atrophic vaginitis."
        },
        {
            "ICD_10_Code": "N95.2",
            "ICD_Description": "N95.2 stands for Postmenopausal atrophic vaginitis."
        },
        {
            "ICD_10_Code": "Z79.890",
            "ICD_Description": "Z79.890 stands for Other long term (current) drug therapy."
        }
    ],
    "ESZOPICLONE 3 MG ORAL TABLET": [
        {
            "ICD_10_Code": "F51.01",
            "ICD_Description": "F51.01 stands for Nonorganic hypersomnia with excessive daytime sleepiness, without long sleep time."
        },
        {
            "ICD_10_Code": "G47.00",
            "ICD_Description": "G47.00 stands for Disorders of initiating and maintaining sleep, unspecified."
        },
        {
            "ICD_10_Code": "G47.01",
            "ICD_Description": "G47.01 stands for Insomnia due to a known physiological condition."
        },
        {
            "ICD_10_Code": "G47.09",
            "ICD_Description": "G47.09 stands for Disorders of initiating and maintaining sleep, unspecified."
        }
    ],
    "EUCRISA 2% OINT": [
        {
            "ICD_10_Code": "L20.9",
            "ICD_Description": "L20.9 stands for Atopic dermatitis, unspecified."
        }
    ],
    "EUFLEXXA 10MG/ML SOSY": [
        {
            "ICD_10_Code": "M17.10",
            "ICD_Description": "M17.10 stands for Unilateral primary osteoarthritis, knee."
        },
        {
            "ICD_10_Code": "M17.11",
            "ICD_Description": "M17.11 stands for Unilateral primary osteoarthritis, right knee."
        },
        {
            "ICD_10_Code": "M17.12",
            "ICD_Description": "M17.12 stands for Unilateral primary osteoarthritis, right knee."
        },
        {
            "ICD_10_Code": "M17.9",
            "ICD_Description": "M17.9 stands for Gonarthrosis, unspecified."
        }
    ],
    "EYSUVIS 0.25 % OPHTHALMIC SUSPENSION": [
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.124",
            "ICD_Description": "H04.124 stands for Hordeolum internum of right lower eyelid."
        },
        {
            "ICD_10_Code": "H04.125",
            "ICD_Description": "H04.125 stands for Chalazion of upper eyelid, right eye."
        }
    ],
    "FARXIGA 10MG TAB": [
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "I50.9",
            "ICD_Description": "I50.9 stands for Heart failure, unspecified."
        },
        {
            "ICD_10_Code": "N18.9",
            "ICD_Description": "N18.9 stands for Chronic kidney disease, unspecified."
        }
    ],
    "FEMRING 0.05MG/24HR RING": [
        {
            "ICD_10_Code": "N95.1",
            "ICD_Description": "N95.1 stands for Postmenopausal atrophic vaginitis."
        }
    ],
    "FLUTICASONE PROPIONATE HFA 110 MCG/ACT INHALATION AEROSOL": [
        {
            "ICD_10_Code": "J45.30",
            "ICD_Description": "J45.30 stands for Mild intermittent asthma, uncomplicated."
        },
        {
            "ICD_10_Code": "J45.40",
            "ICD_Description": "J45.40 stands for Moderate persistent asthma, uncomplicated."
        },
        {
            "ICD_10_Code": "J45.50",
            "ICD_Description": "J45.50 stands for Mixed asthma, unspecified."
        },
        {
            "ICD_10_Code": "J45.909",
            "ICD_Description": "J45.909 stands for Asthma, unspecified, without status asthmaticus."
        }
    ],
    "FREESTYLE LIBRE 3 SENSOR": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "Z79.4",
            "ICD_Description": "Z79.4 stands for Long term (current) use of insulin pump."
        },
        {
            "ICD_10_Code": "Z79.84",
            "ICD_Description": "Z79.84 stands for Long-term (current) use of insulin pump."
        }
    ],
    "GEMTESA 75 MG ORAL TABLET": [
        {
            "ICD_10_Code": "N32.81",
            "ICD_Description": "N32.81 stands for Other specified disorders of bladder."
        },
        {
            "ICD_10_Code": "R39.15",
            "ICD_Description": "R39.15 stands for Mixed urinary incontinence."
        },
        {
            "ICD_10_Code": "R39.16",
            "ICD_Description": "R39.16 stands for Mixed incontinence."
        }
    ],
    "GEMTESA 75MG TAB": [
        {
            "ICD_10_Code": "N32.81",
            "ICD_Description": "N32.81 stands for Other specified disorders of bladder."
        },
        {
            "ICD_10_Code": "R39.15",
            "ICD_Description": "R39.15 stands for Mixed urinary incontinence."
        },
        {
            "ICD_10_Code": "R39.16",
            "ICD_Description": "R39.16 stands for Mixed incontinence."
        }
    ],
    "GVOKE HYPOPEN 2-PACK 1 MG/0.2ML SUBCUTANEOUS SOLUTION AUTO-INJECTOR": [
        {
            "ICD_10_Code": "E16.2",
            "ICD_Description": "E16.2 stands for Nonproliferative diabetic retinopathy with macular edema."
        }
    ],
    "IBSRELA 50MG TABLET": [
        {
            "ICD_10_Code": "K58.1",
            "ICD_Description": "K58.1 stands for Irritable bowel syndrome with diarrhea."
        }
    ],
    "IBUPROFEN-FAMOTIDINE 800-26.6 MG ORAL TABLET": [
        {
            "ICD_10_Code": "M06.00",
            "ICD_Description": "M06.00 stands for Rheumatoid arthritis without organ or systems involvement."
        },
        {
            "ICD_10_Code": "M06.9",
            "ICD_Description": "M06.9 stands for Rheumatoid arthritis, unspecified."
        },
        {
            "ICD_10_Code": "M06.9",
            "ICD_Description": "M06.9 stands for Rheumatoid arthritis, unspecified."
        },
        {
            "ICD_10_Code": "M15.0",
            "ICD_Description": "M15.0 stands for Polyarthrosis, unspecified."
        },
        {
            "ICD_10_Code": "M15.9",
            "ICD_Description": "M15.9 stands for Osteoarthritis, unspecified site."
        },
        {
            "ICD_10_Code": "M17.0",
            "ICD_Description": "M17.0 stands for Unilateral primary osteoarthritis, hip."
        },
        {
            "ICD_10_Code": "M17.9",
            "ICD_Description": "M17.9 stands for Gonarthrosis, unspecified."
        },
        {
            "ICD_10_Code": "M19.90",
            "ICD_Description": "M19.90 stands for Unspecified osteoarthritis, unspecified site."
        }
    ],
    "ICOSAPENT ETHYL 1 GM ORAL CAPSULE": [
        {
            "ICD_10_Code": "E78.1",
            "ICD_Description": "E78.1 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "I20.9",
            "ICD_Description": "I20.9 stands for Angina pectoris, unspecified."
        },
        {
            "ICD_10_Code": "I25.10",
            "ICD_Description": "I25.10 stands for Atherosclerotic heart disease of native coronary artery without angina pectoris."
        }
    ],
    "IMVEXXY STARTER PACK 4 MCG VAGINAL INSERT": [
        {
            "ICD_10_Code": "N94.1",
            "ICD_Description": "N94.1 stands for Premenstrual tension syndrome."
        },
        {
            "ICD_10_Code": "N95.1",
            "ICD_Description": "N95.1 stands for Postmenopausal atrophic vaginitis."
        },
        {
            "ICD_10_Code": "N95.2",
            "ICD_Description": "N95.2 stands for Postmenopausal atrophic vaginitis."
        }
    ],
    "INSULIN DEGLUDEC FLEXTOUCH 200 UNIT/ML SUBCUTANEOUS SOLUTION PEN-INJECTOR": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E13.9",
            "ICD_Description": "E13.9 stands for Other specified diabetes mellitus with other specified complication."
        }
    ],
    "INSULIN GLARGINE-YFGN 100 UNIT/ML SUBCUTANEOUS SOLUTION PEN-INJECTOR": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E13.9",
            "ICD_Description": "E13.9 stands for Other specified diabetes mellitus with other specified complication."
        }
    ],
    "INTRAROSA 6.5MG INSERT": [
        {
            "ICD_10_Code": "N94.10",
            "ICD_Description": "N94.10 stands for Postmenopausal atrophic vaginitis."
        },
        {
            "ICD_10_Code": "N94.11",
            "ICD_Description": "N94.11 stands for Postmenopausal atrophic vaginitis."
        },
        {
            "ICD_10_Code": "N94.12",
            "ICD_Description": "N94.12 stands for Atrophic vaginitis."
        },
        {
            "ICD_10_Code": "N94.19",
            "ICD_Description": "N94.19 stands for Other specified atrophic vulvovaginitis."
        }
    ],
    "INVEGA SUSTENNA 234MG INJ": [
        {
            "ICD_10_Code": "F20.0",
            "ICD_Description": "F20.0 stands for Paranoid schizophrenia."
        },
        {
            "ICD_10_Code": "F20.1",
            "ICD_Description": "F20.1 stands for Schizophrenia, paranoid type."
        },
        {
            "ICD_10_Code": "F20.2",
            "ICD_Description": "F20.2 stands for Schizophrenia, catatonic type."
        },
        {
            "ICD_10_Code": "F20.3",
            "ICD_Description": "F20.3 stands for Undifferentiated schizophrenia."
        },
        {
            "ICD_10_Code": "F20.5",
            "ICD_Description": "F20.5 stands for Schizophrenia, continuous with acute exacerbation."
        },
        {
            "ICD_10_Code": "F20.8",
            "ICD_Description": "F20.8 stands for Other schizophrenia."
        },
        {
            "ICD_10_Code": "F20.9",
            "ICD_Description": "F20.9 stands for Schizophrenia, unspecified."
        }
    ],
    "IYUZEH 0.005% SOL": [
        {
            "ICD_10_Code": "H40.11",
            "ICD_Description": "H40.11 stands for Primary open-angle glaucoma, moderate stage."
        },
        {
            "ICD_10_Code": "H40.12",
            "ICD_Description": "H40.12 stands for Primary open-angle glaucoma."
        },
        {
            "ICD_10_Code": "H40.13",
            "ICD_Description": "H40.13 stands for Primary angle-closure glaucoma, moderate stage."
        },
        {
            "ICD_10_Code": "H40.811",
            "ICD_Description": "H40.811 stands for Primary open-angle glaucoma, low-tension."
        },
        {
            "ICD_10_Code": "H40.812",
            "ICD_Description": "H40.812 stands for Primary open-angle glaucoma, stage unspecified, bilateral."
        },
        {
            "ICD_10_Code": "H40.813",
            "ICD_Description": "H40.813 stands for Other acute angle-closure glaucoma."
        }
    ],
    "JANUMET 50-1000MG TAB": [
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.69",
            "ICD_Description": "E11.69 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.8",
            "ICD_Description": "E11.8 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "JANUVIA 100MG TAB": [
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.69",
            "ICD_Description": "E11.69 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.8",
            "ICD_Description": "E11.8 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "JARDIANCE 25MG TAB": [
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "I25.10",
            "ICD_Description": "I25.10 stands for Atherosclerotic heart disease of native coronary artery without angina pectoris."
        },
        {
            "ICD_10_Code": "N18.9",
            "ICD_Description": "N18.9 stands for Chronic kidney disease, unspecified."
        }
    ],
    "JORNAY PM 20 MG ORAL CAPSULE EXTENDED RELEASE 24 HOUR": [
        {
            "ICD_10_Code": "F90.0",
            "ICD_Description": "F90.0 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.1",
            "ICD_Description": "F90.1 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.2",
            "ICD_Description": "F90.2 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        }
    ],
    "JUBLIA 10 % SOLUTION": [
        {
            "ICD_10_Code": "B35.1",
            "ICD_Description": "B35.1 stands for Tinea unguium."
        }
    ],
    "KERENDIA 10 MG ORAL TABLET": [
        {
            "ICD_10_Code": "E11.22",
            "ICD_Description": "E11.22 stands for Type 2 diabetes mellitus with diabetic nephropathy."
        }
    ],
    "KERENDIA 10MG TAB": [
        {
            "ICD_10_Code": "E11.22",
            "ICD_Description": "E11.22 stands for Type 2 diabetes mellitus with diabetic nephropathy."
        },
        {
            "ICD_10_Code": "N18.3",
            "ICD_Description": "N18.3 stands for Chronic kidney disease, stage 3 (moderate)."
        },
        {
            "ICD_10_Code": "N18.4",
            "ICD_Description": "N18.4 stands for Chronic kidney disease, stage 4."
        }
    ],
    "LACTULOSE 10 GM ORAL PACKET": [
        {
            "ICD_10_Code": "K59.00",
            "ICD_Description": "K59.00 stands for Constipation, unspecified."
        }
    ],
    "LEVEMIR FLEXPEN 100 UNIT/ML SUBCUTANEOUS SOLUTION PEN-INJECTOR": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E13.9",
            "ICD_Description": "E13.9 stands for Other specified diabetes mellitus with other specified complication."
        }
    ],
    "LIDOCAINE 5 % EXTERNAL PATCH": [
        {
            "ICD_10_Code": "B02.9",
            "ICD_Description": "B02.9 stands for Zoster without complications."
        },
        {
            "ICD_10_Code": "G53.0",
            "ICD_Description": "G53.0 stands for Trigeminal neuralgia."
        }
    ],
    "LINZESS 72MCG CAP": [
        {
            "ICD_10_Code": "K58.9",
            "ICD_Description": "K58.9 stands for Irritable bowel syndrome without diarrhea."
        },
        {
            "ICD_10_Code": "K59.00",
            "ICD_Description": "K59.00 stands for Constipation, unspecified."
        },
        {
            "ICD_10_Code": "K59.09",
            "ICD_Description": "K59.09 stands for Other functional intestinal disorders."
        }
    ],
    "LIRAGLUTIDE 18 MG/3ML SUBCUTANEOUS SOLUTION PEN-INJECTOR": [
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.69",
            "ICD_Description": "E11.69 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.8",
            "ICD_Description": "E11.8 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "LO LOESTRIN FE 1 MG-10 MCG /10 MCG TABLET": [
        {
            "ICD_10_Code": "Z30.011",
            "ICD_Description": "Z30.011 stands for Encounter for initial prescription of combined oral contraceptive."
        },
        {
            "ICD_10_Code": "Z30.09",
            "ICD_Description": "Z30.09 stands for Encounter for contraceptive management."
        },
        {
            "ICD_10_Code": "Z30.41",
            "ICD_Description": "Z30.41 stands for Encounter for initial prescription of contraceptive pills."
        }
    ],
    "LYBALVI 10-10 MG ORAL TABLET": [
        {
            "ICD_10_Code": "F20.9",
            "ICD_Description": "F20.9 stands for Schizophrenia, unspecified."
        },
        {
            "ICD_10_Code": "F31.13",
            "ICD_Description": "F31.13 stands for Bipolar I disorder, current episode mixed, moderate."
        },
        {
            "ICD_10_Code": "F31.14",
            "ICD_Description": "F31.14 stands for Bipolar I disorder, current episode mixed, severe, with psychotic features."
        },
        {
            "ICD_10_Code": "F31.9",
            "ICD_Description": "F31.9 stands for Bipolar affective disorder, unspecified."
        },
        {
            "ICD_10_Code": "F32.9",
            "ICD_Description": "F32.9 stands for Major depressive disorder, single episode, unspecified."
        },
        {
            "ICD_10_Code": "F33.9",
            "ICD_Description": "F33.9 stands for Major depressive disorder, single episode, unspecified."
        }
    ],
    "LYBALVI 20-10 MG ORAL TABLET": [
        {
            "ICD_10_Code": "F20.9",
            "ICD_Description": "F20.9 stands for Schizophrenia, unspecified."
        },
        {
            "ICD_10_Code": "F31.13",
            "ICD_Description": "F31.13 stands for Bipolar I disorder, current episode mixed, moderate."
        },
        {
            "ICD_10_Code": "F31.14",
            "ICD_Description": "F31.14 stands for Bipolar I disorder, current episode mixed, severe, with psychotic features."
        },
        {
            "ICD_10_Code": "F31.9",
            "ICD_Description": "F31.9 stands for Bipolar affective disorder, unspecified."
        }
    ],
    "LYBALVI 5-10 MG ORAL TABLET": [
        {
            "ICD_10_Code": "F20.9",
            "ICD_Description": "F20.9 stands for Schizophrenia, unspecified."
        },
        {
            "ICD_10_Code": "F31.9",
            "ICD_Description": "F31.9 stands for Bipolar affective disorder, unspecified."
        }
    ],
    "Lidocaine 5% External Patch": [
        {
            "ICD_10_Code": "G53.0",
            "ICD_Description": "G53.0 stands for Trigeminal neuralgia."
        }
    ],
    "METFORMIN HCL 625 MG ORAL TABLET": [
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.69",
            "ICD_Description": "E11.69 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.8",
            "ICD_Description": "E11.8 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "MIEBO 1.338 GM/ML EYE SOLUTION": [
        {
            "ICD_10_Code": "H04.121",
            "ICD_Description": "H04.121 stands for Blepharoconjunctivitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.122",
            "ICD_Description": "H04.122 stands for Blepharitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        }
    ],
    "MIEBO 1.338 GM/ML OPHTHALMIC SOLUTION": [
        {
            "ICD_10_Code": "H04.121",
            "ICD_Description": "H04.121 stands for Blepharoconjunctivitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.122",
            "ICD_Description": "H04.122 stands for Blepharitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        }
    ],
    "MIRABEGRON ER 25 MG ORAL TABLET EXTENDED RELEASE 24 HOUR": [
        {
            "ICD_10_Code": "N31.9",
            "ICD_Description": "N31.9 stands for Unspecified disorder of bladder."
        },
        {
            "ICD_10_Code": "N32.81",
            "ICD_Description": "N32.81 stands for Other specified disorders of bladder."
        },
        {
            "ICD_10_Code": "R32",
            "ICD_Description": "R32 stands for Unspecified incontinence of urine."
        }
    ],
    "MODAFINIL 100 MG ORAL TABLET": [
        {
            "ICD_10_Code": "G47.26",
            "ICD_Description": "G47.26 stands for Hypersomnia with long sleep time."
        },
        {
            "ICD_10_Code": "G47.33",
            "ICD_Description": "G47.33 stands for Obstructive sleep apnea (adult) (pediatric)."
        },
        {
            "ICD_10_Code": "G47.411",
            "ICD_Description": "G47.411 stands for Narcolepsy without cataplexy."
        },
        {
            "ICD_10_Code": "G47.419",
            "ICD_Description": "G47.419 stands for Narcolepsy without cataplexy, unspecified."
        }
    ],
    "MOUNJARO": [
        {
            "ICD_10_Code": "E11.22",
            "ICD_Description": "E11.22 stands for Type 2 diabetes mellitus with diabetic nephropathy."
        },
        {
            "ICD_10_Code": "E11.42",
            "ICD_Description": "E11.42 stands for Type 2 diabetes mellitus with diabetic nephropathy."
        },
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "MYFEMBREE 40-1-0.5 MG ORAL TABLET": [
        {
            "ICD_10_Code": "N80.0",
            "ICD_Description": "N80.0 stands for Endometriosis of uterus."
        },
        {
            "ICD_10_Code": "N80.1",
            "ICD_Description": "N80.1 stands for Endometriosis of uterus."
        },
        {
            "ICD_10_Code": "N80.2",
            "ICD_Description": "N80.2 stands for Endometriosis of ovary."
        },
        {
            "ICD_10_Code": "N80.3",
            "ICD_Description": "N80.3 stands for Endometrial polyp."
        },
        {
            "ICD_10_Code": "N80.4",
            "ICD_Description": "N80.4 stands for Endometriosis of rectovaginal septum and vagina."
        },
        {
            "ICD_10_Code": "N80.5",
            "ICD_Description": "N80.5 stands for Endometrial hyperplasia."
        },
        {
            "ICD_10_Code": "N80.6",
            "ICD_Description": "N80.6 stands for Endometriosis of ovary."
        },
        {
            "ICD_10_Code": "N80.8",
            "ICD_Description": "N80.8 stands for Other specified noninflammatory disorders of vagina."
        },
        {
            "ICD_10_Code": "N80.9",
            "ICD_Description": "N80.9 stands for Endometriosis, unspecified."
        },
        {
            "ICD_10_Code": "N92.0",
            "ICD_Description": "N92.0 stands for Excessive and frequent menstruation with regular cycle."
        },
        {
            "ICD_10_Code": "N92.1",
            "ICD_Description": "N92.1 stands for Excessive and frequent menstruation with regular cycle."
        },
        {
            "ICD_10_Code": "N92.4",
            "ICD_Description": "N92.4 stands for Amenorrhea, unspecified."
        },
        {
            "ICD_10_Code": "N92.5",
            "ICD_Description": "N92.5 stands for Excessive and frequent menstruation with regular cycle."
        },
        {
            "ICD_10_Code": "N92.6",
            "ICD_Description": "N92.6 stands for Excessive and frequent menstruation with regular cycle."
        },
        {
            "ICD_10_Code": "N93.0",
            "ICD_Description": "N93.0 stands for Female genital prolapse, unspecified."
        },
        {
            "ICD_10_Code": "N93.8",
            "ICD_Description": "N93.8 stands for Other specified abnormal uterine and vaginal bleeding."
        },
        {
            "ICD_10_Code": "N93.9",
            "ICD_Description": "N93.9 stands for Other abnormal uterine and vaginal bleeding."
        }
    ],
    "NAPROXEN-ESOMEPRAZOLE 500-20MG TABLET": [
        {
            "ICD_10_Code": "M06.9",
            "ICD_Description": "M06.9 stands for Rheumatoid arthritis, unspecified."
        },
        {
            "ICD_10_Code": "M15.0",
            "ICD_Description": "M15.0 stands for Polyarthrosis, unspecified."
        },
        {
            "ICD_10_Code": "M45.9",
            "ICD_Description": "M45.9 stands for Ankylosing spondylitis, unspecified."
        }
    ],
    "NEXLIZET 180-10MG TAB": [
        {
            "ICD_10_Code": "E78.0",
            "ICD_Description": "E78.0 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.2",
            "ICD_Description": "E78.2 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.4",
            "ICD_Description": "E78.4 stands for Other hyperlipidemia."
        },
        {
            "ICD_10_Code": "E78.5",
            "ICD_Description": "E78.5 stands for Hyperlipidemia, unspecified."
        },
        {
            "ICD_10_Code": "I25.10",
            "ICD_Description": "I25.10 stands for Atherosclerotic heart disease of native coronary artery without angina pectoris."
        },
        {
            "ICD_10_Code": "I25.110",
            "ICD_Description": "I25.110 stands for Atherosclerotic heart disease of native coronary artery with unstable angina."
        },
        {
            "ICD_10_Code": "I25.119",
            "ICD_Description": "I25.119 stands for Atherosclerotic heart disease of native coronary artery with unstable angina pectoris."
        },
        {
            "ICD_10_Code": "I25.9",
            "ICD_Description": "I25.9 stands for Chronic ischemic heart disease, unspecified."
        }
    ],
    "NEXTSTELLIS 3-14.2 MG ORAL TABLET": [
        {
            "ICD_10_Code": "Z30.011",
            "ICD_Description": "Z30.011 stands for Encounter for initial prescription of combined oral contraceptive."
        },
        {
            "ICD_10_Code": "Z30.9",
            "ICD_Description": "Z30.9 stands for Encounter for contraceptive management."
        }
    ],
    "NOVOLOG FLEXPEN 100U/ML INJ": [
        {
            "ICD_10_Code": "E10.9",
            "ICD_Description": "E10.9 stands for Type 1 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        },
        {
            "ICD_10_Code": "E13.9",
            "ICD_Description": "E13.9 stands for Other specified diabetes mellitus with other specified complication."
        }
    ],
    "NUEDEXTA 20-10 MG ORAL CAPSULE": [
        {
            "ICD_10_Code": "F48.2",
            "ICD_Description": "F48.2 stands for Obsessive-compulsive disorder."
        }
    ],
    "NURTEC 75 MG TABLET DISINTEGRATING": [
        {
            "ICD_10_Code": "G43.009",
            "ICD_Description": "G43.009 stands for Migraine without aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.019",
            "ICD_Description": "G43.019 stands for Migraine with aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        }
    ],
    "NURTEC ODT 75MG TAB": [
        {
            "ICD_10_Code": "G43.009",
            "ICD_Description": "G43.009 stands for Migraine without aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.019",
            "ICD_Description": "G43.019 stands for Migraine with aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        }
    ],
    "NexIUM DR 40MG CER": [
        {
            "ICD_10_Code": "K21.9",
            "ICD_Description": "K21.9 stands for Gastro-esophageal reflux disease without esophagitis."
        },
        {
            "ICD_10_Code": "K25.9",
            "ICD_Description": "K25.9 stands for Gastric ulcer, unspecified."
        },
        {
            "ICD_10_Code": "K26.9",
            "ICD_Description": "K26.9 stands for Gastro-esophageal reflux disease without esophagitis."
        },
        {
            "ICD_10_Code": "K27.9",
            "ICD_Description": "K27.9 stands for Gastro-esophageal reflux disease without esophagitis."
        },
        {
            "ICD_10_Code": "K29.70",
            "ICD_Description": "K29.70 stands for Gastritis, unspecified."
        },
        {
            "ICD_10_Code": "K29.71",
            "ICD_Description": "K29.71 stands for Gastro-esophageal reflux disease with esophagitis."
        },
        {
            "ICD_10_Code": "K31.9",
            "ICD_Description": "K31.9 stands for Indigestion, unspecified."
        }
    ],
    "OMEGA-3-ACID ETHYL ESTERS 1 GM ORAL CAPSULE": [
        {
            "ICD_10_Code": "E78.1",
            "ICD_Description": "E78.1 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.2",
            "ICD_Description": "E78.2 stands for Pure hypercholesterolemia."
        }
    ],
    "OMEPRAZOLE 40 MG ORAL CAPSULE DELAYED RELEASE": [
        {
            "ICD_10_Code": "K21.9",
            "ICD_Description": "K21.9 stands for Gastro-esophageal reflux disease without esophagitis."
        },
        {
            "ICD_10_Code": "K25.9",
            "ICD_Description": "K25.9 stands for Gastric ulcer, unspecified."
        },
        {
            "ICD_10_Code": "K26.9",
            "ICD_Description": "K26.9 stands for Gastro-esophageal reflux disease without esophagitis."
        },
        {
            "ICD_10_Code": "K27.9",
            "ICD_Description": "K27.9 stands for Gastro-esophageal reflux disease without esophagitis."
        },
        {
            "ICD_10_Code": "K29.70",
            "ICD_Description": "K29.70 stands for Gastritis, unspecified."
        },
        {
            "ICD_10_Code": "K29.71",
            "ICD_Description": "K29.71 stands for Gastro-esophageal reflux disease with esophagitis."
        },
        {
            "ICD_10_Code": "K31.9",
            "ICD_Description": "K31.9 stands for Indigestion, unspecified."
        }
    ],
    "OPZELURA 1.5 % EXTERNAL CREAM": [
        {
            "ICD_10_Code": "L20.9",
            "ICD_Description": "L20.9 stands for Atopic dermatitis, unspecified."
        },
        {
            "ICD_10_Code": "L80.9",
            "ICD_Description": "L80.9 stands for Vitiligo, unspecified."
        }
    ],
    "OPZELURA 1.5% CRM": [
        {
            "ICD_10_Code": "L20.9",
            "ICD_Description": "L20.9 stands for Atopic dermatitis, unspecified."
        },
        {
            "ICD_10_Code": "L80",
            "ICD_Description": "L80 stands for Vitiligo."
        }
    ],
    "ORILISSA 150MG TABLET": [
        {
            "ICD_10_Code": "N80.0",
            "ICD_Description": "N80.0 stands for Endometriosis of uterus."
        }
    ],
    "OSPHENA 60 MG ORAL TABLET": [
        {
            "ICD_10_Code": "N94.1",
            "ICD_Description": "N94.1 stands for Premenstrual tension syndrome."
        },
        {
            "ICD_10_Code": "N95.1",
            "ICD_Description": "N95.1 stands for Postmenopausal atrophic vaginitis."
        },
        {
            "ICD_10_Code": "N95.2",
            "ICD_Description": "N95.2 stands for Postmenopausal atrophic vaginitis."
        }
    ],
    "OTEZLA 30MG TAB": [
        {
            "ICD_10_Code": "L40.0",
            "ICD_Description": "L40.0 stands for Psoriasis vulgaris."
        },
        {
            "ICD_10_Code": "L40.50",
            "ICD_Description": "L40.50 stands for Psoriasis, unspecified, generalized."
        }
    ],
    "OZEMPIC (0.25 OR 0.5 MG/DOSE) 2 MG/3ML SUBCUTANEOUS SOLUTION PEN-INJECTOR OZEMPIC": [
        {
            "ICD_10_Code": "E11.22",
            "ICD_Description": "E11.22 stands for Type 2 diabetes mellitus with diabetic nephropathy."
        },
        {
            "ICD_10_Code": "E11.42",
            "ICD_Description": "E11.42 stands for Type 2 diabetes mellitus with diabetic nephropathy."
        },
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "PHEXXI 1.8-1-0.4% GEL": [
        {
            "ICD_10_Code": "Z30.430",
            "ICD_Description": "Z30.430 stands for Encounter for insertion of vaginal ring (contraceptive)."
        },
        {
            "ICD_10_Code": "Z30.431",
            "ICD_Description": "Z30.431 stands for Encounter for insertion of vaginal ring (contraceptive)."
        },
        {
            "ICD_10_Code": "Z30.49",
            "ICD_Description": "Z30.49 stands for Encounter for contraceptive management, unspecified."
        },
        {
            "ICD_10_Code": "Z30.9",
            "ICD_Description": "Z30.9 stands for Encounter for contraceptive management."
        }
    ],
    "PRALUENT 150mg/1ml INJ": [
        {
            "ICD_10_Code": "E78.0",
            "ICD_Description": "E78.0 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.01",
            "ICD_Description": "E78.01 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "I25.10",
            "ICD_Description": "I25.10 stands for Atherosclerotic heart disease of native coronary artery without angina pectoris."
        }
    ],
    "PROCRIT 10000U/ML INJ": [
        {
            "ICD_10_Code": "B20",
            "ICD_Description": "B20 stands for Human immunodeficiency virus [HIV] disease."
        },
        {
            "ICD_10_Code": "D61.1",
            "ICD_Description": "D61.1 stands for Drug-induced aplastic anemia."
        },
        {
            "ICD_10_Code": "D63.0",
            "ICD_Description": "D63.0 stands for Anemia in chronic kidney disease."
        },
        {
            "ICD_10_Code": "D64.81",
            "ICD_Description": "D64.81 stands for Other specified anemias."
        }
    ],
    "PROLIA 60MG INJ": [
        {
            "ICD_10_Code": "M80.0",
            "ICD_Description": "M80.0 stands for Age-related osteoporosis without current pathological fracture."
        },
        {
            "ICD_10_Code": "M80.8",
            "ICD_Description": "M80.8 stands for Other osteoporosis without current pathological fracture."
        },
        {
            "ICD_10_Code": "M80.88",
            "ICD_Description": "M80.88 stands for Other osteoporosis with current pathological fracture."
        },
        {
            "ICD_10_Code": "M81.0",
            "ICD_Description": "M81.0 stands for Postmenopausal osteoporosis."
        },
        {
            "ICD_10_Code": "M81.6",
            "ICD_Description": "M81.6 stands for Osteoporosis of vertebra(e), other site."
        },
        {
            "ICD_10_Code": "M81.8",
            "ICD_Description": "M81.8 stands for Other osteoporosis without current pathological fracture."
        }
    ],
    "QELBREE 200 MG ORAL CAPSULE EXTENDED RELEASE 24 HOUR": [
        {
            "ICD_10_Code": "F90.0",
            "ICD_Description": "F90.0 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.1",
            "ICD_Description": "F90.1 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.2",
            "ICD_Description": "F90.2 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        }
    ],
    "QSYMIA 15-92MG EXT-RELEASE CAPSULE": [
        {
            "ICD_10_Code": "E66.01",
            "ICD_Description": "E66.01 stands for Morbid (severe) obesity due to excess calories."
        },
        {
            "ICD_10_Code": "E66.09",
            "ICD_Description": "E66.09 stands for Obesity, unspecified."
        },
        {
            "ICD_10_Code": "E66.9",
            "ICD_Description": "E66.9 stands for Obesity, unspecified."
        }
    ],
    "QSYMIA 7.5-46MG EXT-RELEASE CAPSULE": [
        {
            "ICD_10_Code": "E66.01",
            "ICD_Description": "E66.01 stands for Morbid (severe) obesity due to excess calories."
        },
        {
            "ICD_10_Code": "E66.812",
            "ICD_Description": "E66.812 stands for Drug-induced obesity due to appetite stimulants."
        },
        {
            "ICD_10_Code": "E66.89",
            "ICD_Description": "E66.89 stands for Other obesity."
        },
        {
            "ICD_10_Code": "E66.9",
            "ICD_Description": "E66.9 stands for Obesity, unspecified."
        }
    ],
    "QULIPTA 60 MG ORAL TABLET": [
        {
            "ICD_10_Code": "G43.009",
            "ICD_Description": "G43.009 stands for Migraine without aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.019",
            "ICD_Description": "G43.019 stands for Migraine with aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        }
    ],
    "QUVIVIQ 25 MG ORAL TABLET": [
        {
            "ICD_10_Code": "F51.01",
            "ICD_Description": "F51.01 stands for Nonorganic hypersomnia with excessive daytime sleepiness, without long sleep time."
        },
        {
            "ICD_10_Code": "G47.00",
            "ICD_Description": "G47.00 stands for Disorders of initiating and maintaining sleep, unspecified."
        },
        {
            "ICD_10_Code": "G47.01",
            "ICD_Description": "G47.01 stands for Insomnia due to a known physiological condition."
        },
        {
            "ICD_10_Code": "G47.09",
            "ICD_Description": "G47.09 stands for Disorders of initiating and maintaining sleep, unspecified."
        }
    ],
    "QUVIVIQ 50 MG ORAL TABLET": [
        {
            "ICD_10_Code": "G47.00",
            "ICD_Description": "G47.00 stands for Disorders of initiating and maintaining sleep, unspecified."
        },
        {
            "ICD_10_Code": "G47.01",
            "ICD_Description": "G47.01 stands for Insomnia due to a known physiological condition."
        },
        {
            "ICD_10_Code": "G47.09",
            "ICD_Description": "G47.09 stands for Disorders of initiating and maintaining sleep, unspecified."
        }
    ],
    "RELISTOR 150MG TAB": [
        {
            "ICD_10_Code": "K59.00",
            "ICD_Description": "K59.00 stands for Constipation, unspecified."
        },
        {
            "ICD_10_Code": "Z79.891",
            "ICD_Description": "Z79.891 stands for Long-term (current) use of other medications."
        }
    ],
    "REPATHA SURECLICK 140MG/ML INJ": [
        {
            "ICD_10_Code": "E78.00",
            "ICD_Description": "E78.00 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.01",
            "ICD_Description": "E78.01 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.02",
            "ICD_Description": "E78.02 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.5",
            "ICD_Description": "E78.5 stands for Hyperlipidemia, unspecified."
        },
        {
            "ICD_10_Code": "I25.10",
            "ICD_Description": "I25.10 stands for Atherosclerotic heart disease of native coronary artery without angina pectoris."
        }
    ],
    "RHOFADE 1% CRM": [
        {
            "ICD_10_Code": "L71.0",
            "ICD_Description": "L71.0 stands for Folliculitis decalvans."
        },
        {
            "ICD_10_Code": "L71.9",
            "ICD_Description": "L71.9 stands for Folliculitis, unspecified."
        }
    ],
    "RINVOQ 15 MG ORAL TABLET EXTENDED RELEASE 24 HOUR": [
        {
            "ICD_10_Code": "L20.9",
            "ICD_Description": "L20.9 stands for Atopic dermatitis, unspecified."
        },
        {
            "ICD_10_Code": "M05.79",
            "ICD_Description": "M05.79 stands for Rheumatoid arthritis with other involvement of other organs or systems."
        },
        {
            "ICD_10_Code": "M45.9",
            "ICD_Description": "M45.9 stands for Ankylosing spondylitis, unspecified."
        }
    ],
    "RYBELSUS 7 MG ORAL TABLET": [
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.69",
            "ICD_Description": "E11.69 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.8",
            "ICD_Description": "E11.8 stands for Type 2 diabetes mellitus with other specified complications."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "SKYRIZI PEN 150 MG/ML SUBCUTANEOUS SOLUTION AUTO-INJECTOR": [
        {
            "ICD_10_Code": "K50.00",
            "ICD_Description": "K50.00 stands for Crohn's disease of small intestine without complications."
        },
        {
            "ICD_10_Code": "K51.0",
            "ICD_Description": "K51.0 stands for Ulcerative (chronic) pancolitis."
        },
        {
            "ICD_10_Code": "L40.0",
            "ICD_Description": "L40.0 stands for Psoriasis vulgaris."
        },
        {
            "ICD_10_Code": "M07.9",
            "ICD_Description": "M07.9 stands for Psoriatic arthropathy, unspecified."
        }
    ],
    "SOTYKTU 6 MG ORAL TABLET": [
        {
            "ICD_10_Code": "L40.0",
            "ICD_Description": "L40.0 stands for Psoriasis vulgaris."
        },
        {
            "ICD_10_Code": "L40.8",
            "ICD_Description": "L40.8 stands for Other psoriasis."
        },
        {
            "ICD_10_Code": "L40.9",
            "ICD_Description": "L40.9 stands for Psoriasis, unspecified."
        }
    ],
    "STEGLATRO 15MG TAB": [
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "Slynd 4mg Tablet": [
        {
            "ICD_10_Code": "Z30.011",
            "ICD_Description": "Z30.011 stands for Encounter for initial prescription of combined oral contraceptive."
        },
        {
            "ICD_10_Code": "Z30.41",
            "ICD_Description": "Z30.41 stands for Encounter for initial prescription of contraceptive pills."
        },
        {
            "ICD_10_Code": "Z79.3",
            "ICD_Description": "Z79.3 stands for Long-term (current) use of oral contraceptives."
        }
    ],
    "TACROLIMUS 0.1 % EXTERNAL OINTMENT": [
        {
            "ICD_10_Code": "L20.9",
            "ICD_Description": "L20.9 stands for Atopic dermatitis, unspecified."
        }
    ],
    "TALICIA 250-12.5-10 MG ORAL CAPSULE DELAYED RELEASE": [
        {
            "ICD_10_Code": "A04.81",
            "ICD_Description": "A04.81 stands for Other specified bacterial intestinal infections."
        }
    ],
    "TESTOSTERONE CYPIONATE 200 MG/ML INTRAMUSCULAR SOLUTION": [
        {
            "ICD_10_Code": "E29.1",
            "ICD_Description": "E29.1 stands for Testicular hypofunction."
        },
        {
            "ICD_10_Code": "E29.9",
            "ICD_Description": "E29.9 stands for Testicular hypofunction, unspecified."
        }
    ],
    "TRETINOIN 0.025 % EXTERNAL CREAM": [
        {
            "ICD_10_Code": "L70.0",
            "ICD_Description": "L70.0 stands for Acne vulgaris."
        },
        {
            "ICD_10_Code": "L70.9",
            "ICD_Description": "L70.9 stands for Acne, unspecified."
        }
    ],
    "TRETINOIN 0.025% CRM": [
        {
            "ICD_10_Code": "L70.0",
            "ICD_Description": "L70.0 stands for Acne vulgaris."
        },
        {
            "ICD_10_Code": "L71.0",
            "ICD_Description": "L71.0 stands for Folliculitis decalvans."
        },
        {
            "ICD_10_Code": "L71.9",
            "ICD_Description": "L71.9 stands for Folliculitis, unspecified."
        }
    ],
    "TRETINOIN 0.05% CREAM": [
        {
            "ICD_10_Code": "L70.0",
            "ICD_Description": "L70.0 stands for Acne vulgaris."
        },
        {
            "ICD_10_Code": "L71.0",
            "ICD_Description": "L71.0 stands for Folliculitis decalvans."
        },
        {
            "ICD_10_Code": "L71.9",
            "ICD_Description": "L71.9 stands for Folliculitis, unspecified."
        }
    ],
    "TRULANCE 3 MG ORAL TABLET": [
        {
            "ICD_10_Code": "K58.1",
            "ICD_Description": "K58.1 stands for Irritable bowel syndrome with diarrhea."
        },
        {
            "ICD_10_Code": "K59.04",
            "ICD_Description": "K59.04 stands for Constipation, unspecified."
        }
    ],
    "TRULICITY 1.5MG/0.5ML INJ": [
        {
            "ICD_10_Code": "E11.65",
            "ICD_Description": "E11.65 stands for Type 2 diabetes mellitus with hyperglycemia with foot ulcer."
        },
        {
            "ICD_10_Code": "E11.9",
            "ICD_Description": "E11.9 stands for Type 2 diabetes mellitus without complications."
        }
    ],
    "TWIRLA 120-30 MCG/24HR TRANSDERMAL PATCH WEEKLY": [
        {
            "ICD_10_Code": "Z30.09",
            "ICD_Description": "Z30.09 stands for Encounter for contraceptive management."
        },
        {
            "ICD_10_Code": "Z30.41",
            "ICD_Description": "Z30.41 stands for Encounter for initial prescription of contraceptive pills."
        },
        {
            "ICD_10_Code": "Z79.3",
            "ICD_Description": "Z79.3 stands for Long-term (current) use of oral contraceptives."
        }
    ],
    "TYRVAYA 0.03 MG/ACT NASAL SOLUTION": [
        {
            "ICD_10_Code": "H04.121",
            "ICD_Description": "H04.121 stands for Blepharoconjunctivitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.122",
            "ICD_Description": "H04.122 stands for Blepharitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        }
    ],
    "UBRELVY 100 MG ORAL TABLET": [
        {
            "ICD_10_Code": "G43.009",
            "ICD_Description": "G43.009 stands for Migraine without aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.019",
            "ICD_Description": "G43.019 stands for Migraine with aura, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        }
    ],
    "URSODIOL 400MG CAP": [
        {
            "ICD_10_Code": "K74.3",
            "ICD_Description": "K74.3 stands for Primary biliary cholangitis."
        },
        {
            "ICD_10_Code": "K80.20",
            "ICD_Description": "K80.20 stands for Calculus of gallbladder with other cholecystitis without obstruction."
        },
        {
            "ICD_10_Code": "K83.0",
            "ICD_Description": "K83.0 stands for Cholangitis."
        },
        {
            "ICD_10_Code": "Z79.899",
            "ICD_Description": "Z79.899 stands for Other long term (current) drug therapy."
        }
    ],
    "VASCEPA 1GM CAP": [
        {
            "ICD_10_Code": "E78.1",
            "ICD_Description": "E78.1 stands for Pure hypercholesterolemia."
        },
        {
            "ICD_10_Code": "E78.2",
            "ICD_Description": "E78.2 stands for Pure hypercholesterolemia."
        }
    ],
    "VELPHORO 500MG CHEW": [
        {
            "ICD_10_Code": "E83.52",
            "ICD_Description": "E83.52 stands for Hypophosphatemia."
        },
        {
            "ICD_10_Code": "N18.5",
            "ICD_Description": "N18.5 stands for Chronic kidney disease, stage 5."
        },
        {
            "ICD_10_Code": "N18.6",
            "ICD_Description": "N18.6 stands for End stage renal disease."
        }
    ],
    "VEMLIDY 25 MG ORAL TABLET": [
        {
            "ICD_10_Code": "B18.1",
            "ICD_Description": "B18.1 stands for Chronic viral hepatitis C."
        },
        {
            "ICD_10_Code": "B18.2",
            "ICD_Description": "B18.2 stands for Chronic viral hepatitis C."
        },
        {
            "ICD_10_Code": "B18.9",
            "ICD_Description": "B18.9 stands for Chronic viral hepatitis, unspecified."
        }
    ],
    "VEMLIDY 25MG TAB": [
        {
            "ICD_10_Code": "B18.1",
            "ICD_Description": "B18.1 stands for Chronic viral hepatitis C."
        },
        {
            "ICD_10_Code": "B18.9",
            "ICD_Description": "B18.9 stands for Chronic viral hepatitis, unspecified."
        }
    ],
    "VEOZAH 45 MG ORAL TABLET": [
        {
            "ICD_10_Code": "N95.1",
            "ICD_Description": "N95.1 stands for Postmenopausal atrophic vaginitis."
        }
    ],
    "VEVYE 0.1 % OPHTHALMIC SOLUTION": [
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.124",
            "ICD_Description": "H04.124 stands for Hordeolum internum of right lower eyelid."
        },
        {
            "ICD_10_Code": "H04.125",
            "ICD_Description": "H04.125 stands for Chalazion of upper eyelid, right eye."
        }
    ],
    "VEVYE 0.1% SOL": [
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.124",
            "ICD_Description": "H04.124 stands for Hordeolum internum of right lower eyelid."
        },
        {
            "ICD_10_Code": "H04.125",
            "ICD_Description": "H04.125 stands for Chalazion of upper eyelid, right eye."
        }
    ],
    "VOQUEZNA 10MG TAB": [
        {
            "ICD_10_Code": "K21.0",
            "ICD_Description": "K21.0 stands for Gastro-esophageal reflux disease with esophagitis."
        },
        {
            "ICD_10_Code": "K21.9",
            "ICD_Description": "K21.9 stands for Gastro-esophageal reflux disease without esophagitis."
        }
    ],
    "VOQUEZNA 20 MG ORAL TABLET": [
        {
            "ICD_10_Code": "K21.0",
            "ICD_Description": "K21.0 stands for Gastro-esophageal reflux disease with esophagitis."
        },
        {
            "ICD_10_Code": "K21.9",
            "ICD_Description": "K21.9 stands for Gastro-esophageal reflux disease without esophagitis."
        }
    ],
    "VOQUEZNA 20MG TAB": [
        {
            "ICD_10_Code": "K21.0",
            "ICD_Description": "K21.0 stands for Gastro-esophageal reflux disease with esophagitis."
        }
    ],
    "VRAYLAR 1.5 MG CAPSULE": [
        {
            "ICD_10_Code": "F20.9",
            "ICD_Description": "F20.9 stands for Schizophrenia, unspecified."
        },
        {
            "ICD_10_Code": "F31.9",
            "ICD_Description": "F31.9 stands for Bipolar affective disorder, unspecified."
        },
        {
            "ICD_10_Code": "F32.9",
            "ICD_Description": "F32.9 stands for Major depressive disorder, single episode, unspecified."
        },
        {
            "ICD_10_Code": "F33.9",
            "ICD_Description": "F33.9 stands for Major depressive disorder, single episode, unspecified."
        },
        {
            "ICD_10_Code": "F41.9",
            "ICD_Description": "F41.9 stands for Generalized anxiety disorder."
        }
    ],
    "VTAMA 1% CRM": [
        {
            "ICD_10_Code": "L20.9",
            "ICD_Description": "L20.9 stands for Atopic dermatitis, unspecified."
        },
        {
            "ICD_10_Code": "L40.9",
            "ICD_Description": "L40.9 stands for Psoriasis, unspecified."
        }
    ],
    "VYVANSE 40MG CAPSULE": [
        {
            "ICD_10_Code": "F90.0",
            "ICD_Description": "F90.0 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.1",
            "ICD_Description": "F90.1 stands for Attention-deficit hyperactivity disorder, predominantly inattentive type."
        },
        {
            "ICD_10_Code": "F90.9",
            "ICD_Description": "F90.9 stands for Attention-deficit hyperactivity disorder, unspecified."
        }
    ],
    "WELLBUTRIN XL 150 MG ORAL TABLET EXTENDED RELEASE 24 HOUR": [
        {
            "ICD_10_Code": "F33.1",
            "ICD_Description": "F33.1 stands for Major depressive disorder, recurrent, moderate episode."
        },
        {
            "ICD_10_Code": "F33.8",
            "ICD_Description": "F33.8 stands for Other recurrent depressive disorders."
        },
        {
            "ICD_10_Code": "F33.9",
            "ICD_Description": "F33.9 stands for Major depressive disorder, single episode, unspecified."
        }
    ],
    "XDEMVY 0.25 % OPHTHALMIC SOLUTION": [
        {
            "ICD_10_Code": "B88.0",
            "ICD_Description": "B88.0 stands for Pediculosis, unspecified."
        },
        {
            "ICD_10_Code": "H01.00",
            "ICD_Description": "H01.00 stands for Hordeolum externum."
        }
    ],
    "XHANCE 93MCG/ACT EXHU": [
        {
            "ICD_10_Code": "J31.0",
            "ICD_Description": "J31.0 stands for Chronic rhinitis."
        },
        {
            "ICD_10_Code": "J31.1",
            "ICD_Description": "J31.1 stands for Chronic rhinitis, allergic, and vasomotor."
        },
        {
            "ICD_10_Code": "J33.9",
            "ICD_Description": "J33.9 stands for Nasal polyp, unspecified."
        }
    ],
    "XIFAXAN 550MG TAB": [
        {
            "ICD_10_Code": "K58.0",
            "ICD_Description": "K58.0 stands for Irritable bowel syndrome with diarrhea."
        },
        {
            "ICD_10_Code": "K72.91",
            "ICD_Description": "K72.91 stands for Hepatic fibrosis, unspecified."
        }
    ],
    "XIFAXAN 550MG TABS": [
        {
            "ICD_10_Code": "K58.0",
            "ICD_Description": "K58.0 stands for Irritable bowel syndrome with diarrhea."
        },
        {
            "ICD_10_Code": "K76.82",
            "ICD_Description": "K76.82 stands for Other specified diseases of liver."
        }
    ],
    "XIIDRA 5 % OPHTHALMIC SOLUTION": [
        {
            "ICD_10_Code": "H04.121",
            "ICD_Description": "H04.121 stands for Blepharoconjunctivitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.122",
            "ICD_Description": "H04.122 stands for Blepharitis, unspecified eyelid, right eye."
        },
        {
            "ICD_10_Code": "H04.123",
            "ICD_Description": "H04.123 stands for Hordeolum and chalazion of upper eyelid, right eye."
        }
    ],
    "ZAVZPRET 10 MG/ACT NASAL SOLUTION": [
        {
            "ICD_10_Code": "G43.909",
            "ICD_Description": "G43.909 stands for Migraine, unspecified, not intractable, without status migrainosus."
        },
        {
            "ICD_10_Code": "G43.919",
            "ICD_Description": "G43.919 stands for Migraine, unspecified, intractable."
        },
        {
            "ICD_10_Code": "G43.929",
            "ICD_Description": "G43.929 stands for Migraine, unspecified, intractable."
        },
        {
            "ICD_10_Code": "G43.939",
            "ICD_Description": "G43.939 stands for Migraine, unspecified, intractable."
        }
    ],
    "ZORYVE 0.3 % EXTERNAL CREAM": [
        {
            "ICD_10_Code": "L40.0",
            "ICD_Description": "L40.0 stands for Psoriasis vulgaris."
        }
    ],
    "ZTLIDO 1.8% FILM": [
        {
            "ICD_10_Code": "G53.0",
            "ICD_Description": "G53.0 stands for Trigeminal neuralgia."
        }
    ],
    "ZTLIDO 1.8% PATCH": [
        {
            "ICD_10_Code": "G53.0",
            "ICD_Description": "G53.0 stands for Trigeminal neuralgia."
        }
    ],
    "Zepbound": [
        {
            "ICD_10_Code": "E66.01",
            "ICD_Description": "E66.01 stands for Morbid (severe) obesity due to excess calories."
        },
        {
            "ICD_10_Code": "E66.3",
            "ICD_Description": "E66.3 stands for Overweight."
        },
        {
            "ICD_10_Code": "E66.9",
            "ICD_Description": "E66.9 stands for Obesity, unspecified."
        },
        {
            "ICD_10_Code": "G47.33",
            "ICD_Description": "G47.33 stands for Obstructive sleep apnea (adult) (pediatric)."
        }
    ]
}